drugset / Trial / NCT02221232

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

NCT02221232

Phase 2 Terminated 64 enrolled Zurex Pharma, Inc.
RandomizedParallel-groupOpen-label

Summary

The purpose of this pilot study is to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied in two different areas when used as a patient preoperative skin preparation.

Timeline

Start
2014-08
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 2 % Topical
Comparator Chlorhexidine Small molecule 70 % Topical
Subject ZuraPrep Unknown 70 % Topical

Indications

No indication recorded.